Skip to content

Intravenous dexamethasone as an adjunct to improve the preemptive analgesia by peri-incisional and intraperitoneal ropivacaine in laparoscopic cholecystectomy: A prospective, randomized, double-blind controlled trial

Intravenous dexamethasone as an adjunct to improve the preemptive analgesia by peri-incisional and intraperitoneal ropivacaine in laparoscopic cholecystectomy: A prospective, randomized, double-blind controlled trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800015436
Enrollment
Unknown
Registered
2018-03-30
Start date
2018-04-01
Completion date
Unknown
Last updated
2018-06-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Laparoscopic Cholecystectomy

Interventions

DEX group:Intravenous dexamethasone+ peri-incisional and intraperitoneal ropivacaine
NS group:Intravenous normal saline + peri-incisional and intraperitoneal ropivacaine
BK group:Intravenous normal saline + peri-incisional and intraperitoneal normal saline

Sponsors

The Second Affiliated Hospital of Nanchang University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: Patients who were scheduled for elective laparoscopic cholecystectomy under general anesthesia because of gall bladder polyps, chronic cholecystitis or gallstones were enrolled in this study, aged between 18 and 75 years, with an American Society of Anesthesiologists physical status classification of I to II.

Exclusion criteria

Exclusion criteria: Patients with acute cholecystitis, chronic pain diseases except gallstone disease, renal or hepatic disease, active peptic ulcer diseaseprior medication with corticosteroids usage, a history of alcohol or drug abuse, ASA physical status III or greater, contraindications to any of the drugs used in the study, and pregnancy. Moreover, patients were excluded if the operation was converted to an open procedure, a drainage catheter was inserted or the duration of surgery 80 min.

Design outcomes

Primary

MeasureTime frame
Pain score within 48 hours after surgery;

Secondary

MeasureTime frame
total dosage of opioids drug;side effects of nausea and vomiting;

Countries

China

Contacts

Public ContactJun Ying

The Second Affiliated Hospital of Nanchang University

838857687@qq.com+86 13330121796

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026